$23.69
al cierre: Nov 19, 4:00 PM EST
$23.69
N/A
After hour: 4:00 PM EST
Immunovant informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Immunovant utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
IMVT | Immunovant | -$0.76 | -$0.71 | — | — | $0.00 | $2.40M | — | — | 02/05/2026 | |
IMVT | Immunovant | -$0.74 | -$0.72 | -$0.73 | -1.39% | $0.00 | — | $0.00 | — | 11/10/2025 | |
IMVT | Immunovant | -$0.60 | -$0.68 | -$0.71 | -4.41% | $0.00 | — | $0.00 | — | 08/11/2025 | |
IMVT | Immunovant | -$0.52 | -$0.72 | -$0.64 | 11.11% | $0.00 | — | $0.00 | — | 05/29/2025 | |
IMVT | Immunovant | -$0.36 | -$0.76 | -$0.76 | 0.00% | $0.00 | — | $0.00 | — | 02/06/2025 | |
IMVT | Immunovant | -$0.45 | -$0.60 | -$0.74 | -23.33% | $0.00 | — | $0.00 | — | 11/07/2024 | |
IMVT | Immunovant | -$0.57 | -$0.53 | -$0.60 | -13.21% | $0.00 | — | $0.00 | — | 08/06/2024 | |
IMVT | Immunovant | -$0.46 | -$0.43 | -$0.52 | -20.93% | $0.00 | — | $0.00 | — | 05/29/2024 | |
IMVT | Immunovant | -$0.49 | -$0.43 | -$0.36 | 16.28% | $0.00 | — | $0.00 | — | 02/12/2024 | |
IMVT | Immunovant | -$0.41 | -$0.48 | -$0.45 | 6.25% | $0.00 | — | $0.00 | — | 11/09/2023 | |
IMVT | Immunovant | -$0.35 | -$0.45 | -$0.57 | -26.67% | $0.00 | — | $0.00 | — | 08/10/2023 | |
IMVT | Immunovant | -$0.41 | -$0.43 | -$0.46 | -6.98% | $0.00 | — | $0.00 | — | 05/22/2023 | |
IMVT | Immunovant | -$0.36 | -$0.39 | -$0.49 | -25.64% | $0.00 | — | $0.00 | — | 02/03/2023 | |
IMVT | Immunovant | -$0.35 | -$0.39 | -$0.41 | -5.13% | $0.00 | — | $0.00 | — | 11/04/2022 | |
IMVT | Immunovant | -$0.31 | -$0.40 | -$0.35 | 12.50% | $0.00 | — | $0.00 | — | 08/05/2022 | |
IMVT | Immunovant | -$0.29 | -$0.38 | -$0.41 | -7.89% | $0.00 | — | $0.00 | — | 06/08/2022 | |
IMVT | Immunovant | -$0.32 | -$0.33 | -$0.36 | -9.09% | $0.00 | — | $0.00 | — | 02/04/2022 | |
IMVT | Immunovant | -$0.25 | -$0.30 | -$0.35 | -16.67% | $0.00 | — | $0.00 | — | 11/05/2021 | |
IMVT | Immunovant | -$0.38 | -$0.30 | -$0.31 | -3.33% | $0.00 | — | $0.00 | — | 08/09/2021 | |
IMVT | Immunovant | -$0.38 | -$0.32 | -$0.29 | 9.38% | $0.00 | — | $0.00 | — | 06/01/2021 | |
IMVT | Immunovant | -$0.28 | — | -$0.32 | — | — | — | $0.00 | — | 02/16/2021 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-11-10 | $-0.73 | $-0.72 | -1.39 % |
| Q1 | 2025-08-11 | $-0.71 | $-0.68 | -4.41 % |
| Q4 | 2025-05-29 | $-0.64 | $-0.72 | 11.1 % |
| Q3 | 2025-02-06 | $-0.76 | $-0.76 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
Está previsto que Immunovant (IMVT) presente resultados el febrero 5, 2026. Los últimos resultados se publicaron el noviembre 10, 2025 para el Q2.
El BPA real fue de $-0.73, que no alcanzó la estimación de $-0.72.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.